Diasorin Logo

Diasorin

Develops immunodiagnostic and molecular diagnostic kits and systems for healthcare and research.

DIA | XMIL

Overview

Corporate Details

ISIN(s):
IT0003492391 (+2 more)
LEI:
8156002878BDF0EE4348
Country:
Italy
Address:
VIA CRESCENTINO, SNC, 13040 SALUGGIA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Diasorin is a global leader in the in vitro diagnostics (IVD) market, specializing in the development, manufacturing, and commercialization of reagent kits and automated systems. The company's core focus is on two primary segments: immunodiagnostics and molecular diagnostics. In immunodiagnostics, Diasorin provides advanced solutions, including its LIAISON® family of analyzers, which detect antibodies and antigens to aid in the diagnosis of diseases. Its molecular diagnostics division offers flexible tools that use targeted and multiplex technologies to identify pathogens in biological specimens, providing healthcare providers with critical, actionable information. The company also operates in the Licensed Technology sector, offering platforms for biomedical research, clinical diagnostics, and drug discovery to help scientists find rapid and reliable answers to complex biological questions.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-07 10:03
Declaration of Voting Results & Voting Rights Announcements
Communication on total amount of voting rights
English 229.7 KB
2025-10-07 10:01
Declaration of Voting Results & Voting Rights Announcements
Comunicazione dell'ammontare complessivo dei diritti di voto
Italian 210.3 KB
2025-09-05 10:34
Declaration of Voting Results & Voting Rights Announcements
Communication on total amount of voting rights
English 206.3 KB
2025-09-05 10:32
Declaration of Voting Results & Voting Rights Announcements
Comunicazione dell'ammontare complessivo dei diritti di voto
Italian 209.6 KB
2025-08-07 11:29
Interim Report
Interim Financial Report as at June 30, 2025
English 3.0 MB
2025-08-04 16:51
Report Publication Announcement
Pubblicazione della Relazione finanziaria semestrale al 30 giugno 2025
Italian 184.4 KB
2025-08-04 15:32
Interim Report
Relazione Finanziaria Semestrale del Gruppo Diasorin al 30 giugno 2025
Italian 3.4 MB
2025-07-31 16:24
Investor Presentation
Diasorin H1 2025 Results Presentation
English 1.4 MB
2025-07-31 16:22
Earnings Release
Revenue Growth and Margin Expansion in H1 2025. FY 2025 Guidance Confirmed
English 342.3 KB
2025-07-31 16:21
Earnings Release
Ricavi in crescita ed incremento della marginalità nel 1° semestre 2025. Confer…
Italian 470.4 KB
2025-07-07 09:34
Declaration of Voting Results & Voting Rights Announcements
Communication on total amount of voting rights
English 210.5 KB
2025-07-07 09:32
Declaration of Voting Results & Voting Rights Announcements
Comunicazione dell'ammontare complessivo dei diritti di voto
Italian 232.4 KB
2025-07-01 08:57
Transaction in Own Shares
Diasorin S.p.A. - Allegato 3F
Italian 91.4 KB
2025-05-12 15:37
Post-Annual General Meeting Information
Pubbicazione del verbale dell'Assemblea degli Azionisti del 28 aprile 2025
Italian 184.1 KB
2025-05-12 15:26
Post-Annual General Meeting Information
Verbale Assemblea Ordinaria degli Azionisti 28 aprile 2025
English 21.1 MB

Automate Your Workflow. Get a real-time feed of all Diasorin filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Diasorin via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
WAKAMOTO PHARMACEUTICAL CO.,LTD. Logo
Develops gastrointestinal and ophthalmic drugs for the health challenges of an aging society.
Japan 4512
WELLBIOTEC CO.,LTD Logo
Diversified in biopharma, EV chargers, and lithium supply for batteries.
South Korea 010600
WHANIN PHARM CO.,LTD Logo
Develops and sells pharmaceuticals, specializing in CNS, cardiovascular, and GI drugs.
South Korea 016580
WooGeneB&GCO.,Ltd Logo
Manufactures veterinary medicines, vaccines, and supplements for livestock and aquatic animals.
South Korea 018620
Xbrane Biopharma Logo
Develops affordable biosimilars for serious diseases using patented, high-yield production tech.
Sweden XBRANE
Xintela AB Logo
Develops stem cell therapies for osteoarthritis and venous leg ulcers using proprietary technology.
Sweden XINT
Xspray Pharma Logo
Develops improved cancer drugs (PKIs) using patented tech to circumvent secondary patents.
Sweden XSPRAY
Y.B Urban Renewal - Residential Development LTD Logo Israel CSURE-M
YUHAN CORPORATION Logo
A pharmaceutical & chemical firm developing drugs, supplements, consumer products, and APIs.
South Korea 000100
YUKI GOSEI KOGYO CO.,LTD. Logo
Manufactures fine chemicals, amino acids, and APIs via organic synthesis for global industries.
Japan 4531

Talk to a Data Expert

Have a question? We'll get back to you promptly.